Vaccinia virus infection of HeLa cells. I. Synthesis of vaccinia DNA in host cell nuclei.
The replication of vaccinia virus is thought to take place exclusively in the cytoplasm of host cells. However, using DNA-DNA hybridization techniques, it can be shown that a significant fraction of the synthesis of vaccinia DNA takes place in the nucleus as well as the cytoplasm. The (3H) thymiding pulse-labeled vaccinia DNA synthesized in the nucleus reaches a maximum at about 3 h after infection, corresponding to the time of maximal DNA synthesis in infected cells. At this time host DNA synthesis drops to about 25% of the rate of the uninfected cells. Even with short labeling times (2 min) the nucleus is found to contain 60% of the incorporated (3H)thymidine, much of which is in vaccinia DNA. Prior inhibition of host nuclear DNA synthesis with mitomycin C, followed by removal of the antibiotic causes a subsequent inhibition of vaccinia DNA synthesis and complete suppression of mature virus. Purified nuclei, isolated from vaccinia-infected cells, also synthesize vaccinia DNA in vitro. Over 90% of the DNA synthesized in vitro by isolated nuclei contain vaccinia-specific sequences.
D002458:Cell Fractionation; D002467:Cell Nucleus / Q000378:metabolism*; D002474:Cell-Free System; D003593:Cytoplasm / Q000378:metabolism / Q000382:microbiology; D004261:DNA Replication; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004279:DNA, Viral / Q000096:biosynthesis*; D005260:Female; D005467:Floxuridine / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D008937:Mitomycins / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014616:Vaccinia virus / Q000254:growth & development / Q000378:metabolism*; D014779:Virus Replication
D004273:DNA, Neoplasm; D004279:DNA, Viral; D008937:Mitomycins; D005467:Floxuridine; D014316:Tritium; D013936:Thymidine